Evaluation of Postoperative Pain in Cases Undergoing Cataract Surgery Under Topical Versus General Anesthesia
NCT ID: NCT07287683
Last Updated: 2025-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE1/PHASE2
50 participants
INTERVENTIONAL
2025-04-02
2026-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The cases will be selected having (ASA1), (ASA II) or (ASA III) physical status in the age range between 20 and 70 years old with cataract eye disease.
This study will be performed in Alexandria Main University Hospital, Egypt. Patients will be followed up at 24 hours, 1 week, and 6 weeks after surgery.
The following measurements will be recorded
1. Pain will be assessed prior to surgery and after surgery using VAS score at 24 hours, 1 week, and 6 weeks after surgery.
2. Need for analgesic intake after surgery will be assessed for the first 48 hours
3. Complications after surgery as irritation, infection ,and foreign body sensation were assessed
4. Patient satisfaction will be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group under general anesthesia for cataract surgery
Patients undergoing cataract surgery will receive general Anaesthesia using intravenous injection and inhalational anaesthetics
General Anaesthesia group
General Anaesthesia will be given to this group undergoing cataract surgery
Group under topical anaesthesia
Patients will receive topical anaesthesia for cataract surgery
Topical Anaesthesia group
This group of patients will only receive topical anaesthesia for Cataract surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Topical Anaesthesia group
This group of patients will only receive topical anaesthesia for Cataract surgery
General Anaesthesia group
General Anaesthesia will be given to this group undergoing cataract surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
radwa saber
Dr. Radwa Saber, lecturer of Anesthesiology, principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Radwa S Raslan, PHD
Role: PRINCIPAL_INVESTIGATOR
AMUH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0307211
Identifier Type: -
Identifier Source: org_study_id